Literature DB >> 28957843

Chronic Liraglutide Administration Fails to Suppress Postprandial Glucagon Levels in Type 1 Diabetic Islet Allograft Recipients With Graft Dysfunction.

Francesco Vendrame1,2, Nathalia Padilla1, Eduardo Peixoto1,3, David Baidal1,2, Violet Lagari1,2, Ana Alvarez Gil1, Alejandro Mantero4, Shari Messinger4, Camillo Ricordi1, Rodolfo Alejandro1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28957843      PMCID： PMC5741482          DOI： 10.1097/TP.0000000000001964

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.

Authors:  Raquel N Faradji; Tatiana Froud; Shari Messinger; Kathy Monroy; Antonello Pileggi; Davide Mineo; Thipaporn Tharavanij; Armando J Mendez; Camillo Ricordi; Rodolfo Alejandro
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

2.  The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial.

Authors:  Caroline K Kramer; Bernard Zinman; Haysook Choi; Philip W Connelly; Ravi Retnakaran
Journal:  J Clin Endocrinol Metab       Date:  2015-07-31       Impact factor: 5.958

Review 3.  The clinical impact of islet transplantation.

Authors:  P Fiorina; A M J Shapiro; C Ricordi; A Secchi
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.